Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Trading on the London Stock Exchange

16 Apr 2014 08:00

RNS Number : 8980E
Polypipe Group PLC
16 April 2014
 



NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (THE "UNITED STATES") (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

For immediate release

 

16 April 2014

 

Polypipe Group plc

 

Admission to Trading on the London Stock Exchange

 

Further to the announcements on 11 April 2014, Polypipe Group plc ("Polypipe" or the "Company") is pleased to announce that its entire issued share capital of 199,999,862 ordinary shares of £0.001 each has today been admitted to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities under the ticker PLP ("Admission").

 

Total voting rights

 

In accordance with the Disclosure and Transparency Rules (DTR 5.6), the Company makes the following disclosure with respect to the share capital and voting rights of the Company. As at 16 April 2014, the share capital of the Company consists of 199,999,862 ordinary shares of £0.001 each with voting rights ("Shares"). The Company does not hold any shares in treasury. Therefore, the total number of shares and voting rights in the Company is 199,999,862.

 

The above figure (199,999,862) may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Polypipe +44 (0) 1709 770 000

David Hall, Chief Executive Officer

Peter Shepherd, Chief Financial Officer

 

Financial Adviser to the Company

Moelis & Company +44 (0) 207 634 3500

Mark Aedy

Liam Beere

 

Joint Sponsors and Joint Bookrunners

Deutsche Bank +44 (0) 20 7545 8000

Lorcan O'Shea

Charles Wilkinson

Simon Gorringe

 

Numis +44 (0) 20 7260 1000

Heraclis Economides

Alex Ham

Richard Thomas

 

Co-Lead Manager

Canaccord Genuity +44 (0) 20 7523 8000

Colin Christie

Bruce Garrow

 

Media Enquiries

Brunswick +44 (0) 20 7404 5959

Azadeh Varzi

Simon Maine  

Important notice

Neither this announcement nor any copy of it may be taken or transmitted, published or distributed, directly or indirectly, into the United States, Australia, Canada, Japan or South Africa or to any persons in any of those jurisdictions or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe any such restrictions.

This announcement does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any Shares or other securities in the United States, Australia, Canada, Japan or South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The Company's initial public offering of Shares (the "Offer") and the distribution of this announcement and other information in connection with the Offer and Admission in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Neither this announcement nor any part of it nor the fact of its distribution shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

This announcement does not constitute an offer to sell or a solicitation of an offer to purchase any securities in the United States or in any jurisdiction in which such offer or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. Securities may not be offered or sold in the United States absent (i) registration under the Securities Act 1933 (as amended) (the "Securities Act") or (ii) an available exemption from registration under the Securities Act. The securities mentioned herein have not been, and will not be, registered under the Securities Act and will not be offered to the public in the United States. There will be no public offer of the securities referred to herein in the United States, Australia, Canada, Japan or South Africa. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa.

This announcement is only addressed to and directed at persons in member states of the European Economic Area ("EEA") who are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC), as amended ("Qualified Investors"). In addition, in the United Kingdom, this announcement is addressed and directed only at Qualified Investors who (i) are persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (ii) are persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, and (iii) to persons to whom it may otherwise be lawful to communicate it to (all such persons being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to relevant persons in the United Kingdom and Qualified Investors in any member state of the EEA other than the United Kingdom, and will be engaged in only with such persons. Other persons should not rely or act upon this announcement or any of its contents

Deutsche Bank, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, and Numis, Canaccord Genuity Limited ("Canaccord Genuity") and Moelis & Company UK LLP ("Moelis & Company") , each of which is authorised and regulated solely by the Financial Conduct Authority, are acting exclusively for the Company and no one else in connection with the Offer and Admission, and will not regard any other person as its client in relation to the Offer and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, nor for providing advice in relation to the Offer or the contents of this announcement or any transaction, arrangement or other matter referred to herein.

In connection with the Offer, Deutsche Bank, Numis and Canaccord Genuity and any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Shares and other securities of the Company or related investments in connection with the Offer or otherwise. Accordingly, references in the Prospectus to the Shares being offered, subscribed, acquired, placed or otherwise dealt in should be read as including any offer to, or subscription, acquisition, placing or dealing by Deutsche Bank, Numis and Canaccord Genuity and any of their respective affiliates acting as investors for their own accounts. In addition, certain of Deutsche Bank, Numis and Canaccord Genuity or their respective affiliates may enter into financing arrangements and swaps in connection with which they or their affiliates may from time to time acquire, hold or dispose of Shares. None of Deutsche Bank, Numis and Canaccord Genuity intends to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

None of Deutsche Bank, Numis, Canaccord Genuity and Moelis & Company, nor any of their respective subsidiary undertakings, affiliates or any of their respective partners, directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXELFFZZFEBBK
Date   Source Headline
6th Apr 20213:30 pmRNSChange of Name
16th Mar 20217:00 amRNSFinal Results
11th Mar 20213:17 pmRNSHolding(s) in Company
5th Mar 20214:17 pmRNSHolding(s) in Company
3rd Mar 20219:24 amRNSHolding(s) in Company
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20214:58 pmRNSTotal Voting Rights
17th Feb 20218:05 amRNSHolding(s) in Company
15th Feb 20214:22 pmRNSDirector/PDMR Shareholding
15th Feb 20211:59 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSResults of placing
10th Feb 20214:52 pmRNSProposed placing of new ordinary shares
10th Feb 20214:50 pmRNSAcquisition of ADEY
2nd Feb 20217:00 amRNSAcquisition of Nu-Heat and Trading Update
1st Feb 20213:57 pmRNSHolding(s) in Company
29th Jan 20215:32 pmRNSHolding(s) in Company
8th Jan 20218:50 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSTrading Update
24th Nov 20208:25 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSTrading Update
2nd Nov 20202:31 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:05 amRNSBlock listing Interim Review
30th Oct 20204:26 pmRNSTotal Voting Rights
29th Oct 20202:32 pmRNSDirector/PDMR Shareholding
19th Oct 202010:09 amRNSHolding(s) in Company
7th Oct 202012:28 pmRNSHolding(s) in Company
6th Oct 202010:19 amRNSHolding(s) in Company
23rd Sep 202010:43 amRNSDirector Declaration
22nd Sep 20203:59 pmRNSDirector/PDMR Shareholding
17th Sep 20204:21 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSHalf-year Report
17th Jul 20204:26 pmRNSNon-Executive Director update
16th Jul 20209:37 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSCOVID-19 Update
30th Jun 20202:41 pmRNSTotal Voting Rights
29th Jun 202012:59 pmRNSDirector Declaration
26th Jun 20204:19 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:57 pmRNSDirector/PDMR Shareholding
23rd Jun 20208:28 amRNSHolding(s) in Company
22nd Jun 20204:14 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
22nd Jun 20203:06 pmRNSNon-Executive Director changes
18th Jun 20204:14 pmRNSDirector/PDMR Shareholding
17th Jun 20208:18 amRNSHolding(s) in Company
3rd Jun 202011:17 amRNSHolding(s) in Company
1st Jun 20201:24 pmRNSTotal Voting Rights
21st May 20203:05 pmRNSResult of AGM
15th May 202012:55 pmRNSHolding(s) in Company
13th May 202010:14 amRNSDirector/PDMR Shareholding
12th May 20204:01 pmRNSAnnual General Meeting 2020 - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.